• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌细胞中pS2基因与雌激素受体的结构和功能

Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells.

作者信息

Stack G, Kumar V, Green S, Ponglikitmongkol M, Berry M, Rio M C, Nunez A M, Roberts M, Koehl C, Bellocq P

出版信息

Cancer Treat Res. 1988;40:185-206. doi: 10.1007/978-1-4613-1733-3_8.

DOI:10.1007/978-1-4613-1733-3_8
PMID:2908650
Abstract

The role of estrogen in the growth of human breast cancers has been investigated at two levels. First, we have studied the pS2 gene, whose transcription is stimulated by estrogen in the human breast cancer cell line, MCF-7. The pS2 gene product is a small, secreted polypeptide currently of unknown function, but with structural features similar to some growth factors. The expression of the pS2 gene has so far been detected only in MCF-7 cells and some breast cancer biopsies. Preliminary studies indicate that pS2 is a potential marker for hormone-dependent breast cancer. Ongoing studies will continue to focus on the implicated role of pS2 in the estrogen-mediated growth of breast cancers and its possible use as a marker for estrogen-dependent tumors. Second, we have analyzed the structure and function of the human ER. The receptor stimulates pS2 gene transcription by interacting with an ERE in the 5'-flanking region of that gene. A mutational analysis of the receptor protein has localized a DNA-binding domain, which determines target gene specificity, and a hormone-binding domain. These domains appear to be the only two regions of the receptor which are absolutely required for the transcription-activating function of the ER in transfection assays with reporter plasmids. The N-terminal region of the protein (regions A and B), which is necessary for increasing the efficiency of gene expression using the pS2 ERE, but not a vitellogenin ERE, may also play a role in transcription activation. Further progress in the characterization of the ER functional domains will require studies on target genes in a more physiological chromatin environment, as well as detailed physical analyses of receptor structure.

摘要

雌激素在人类乳腺癌生长中的作用已在两个层面上进行了研究。首先,我们研究了pS2基因,其转录在人类乳腺癌细胞系MCF - 7中受雌激素刺激。pS2基因产物是一种小的分泌型多肽,目前功能未知,但具有与某些生长因子相似的结构特征。到目前为止,pS2基因的表达仅在MCF - 7细胞和一些乳腺癌活检组织中检测到。初步研究表明,pS2是激素依赖性乳腺癌的一个潜在标志物。正在进行的研究将继续聚焦于pS2在雌激素介导的乳腺癌生长中的作用及其作为雌激素依赖性肿瘤标志物的可能用途。其次,我们分析了人类雌激素受体(ER)的结构和功能。该受体通过与该基因5'侧翼区域的雌激素反应元件(ERE)相互作用来刺激pS2基因转录。对受体蛋白的突变分析确定了一个决定靶基因特异性的DNA结合结构域和一个激素结合结构域。在使用报告质粒的转染实验中,这些结构域似乎是ER转录激活功能绝对必需的仅有的两个区域。该蛋白的N端区域(A和B区),对于使用pS2的ERE提高基因表达效率是必需的,但对卵黄生成素ERE则不是,它可能也在转录激活中发挥作用。ER功能结构域特征的进一步进展将需要在更生理的染色质环境中对靶基因进行研究,以及对受体结构进行详细的物理分析。

相似文献

1
Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells.人乳腺癌细胞中pS2基因与雌激素受体的结构和功能
Cancer Treat Res. 1988;40:185-206. doi: 10.1007/978-1-4613-1733-3_8.
2
Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.雌激素诱导的pS2乳腺癌标志物基因受孤儿核受体ERR家族的转录调控。
Cancer Res. 2001 Sep 15;61(18):6755-61.
3
The pS2 gene, mRNA, and protein: a potential marker for human breast cancer.pS2基因、信使核糖核酸及蛋白质:一种潜在的人类乳腺癌标志物。
Cancer Cells. 1990 Aug-Sep;2(8-9):269-74.
4
Clinical significance of the estrogen regulated pS2 protein in mammary tumors.
Crit Rev Oncol Hematol. 1993 Aug;15(1):13-21. doi: 10.1016/1040-8428(93)90017-x.
5
Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.农药残留β-六氯环己烷在人乳腺癌细胞中的新型雌激素作用。
Cancer Res. 1996 Dec 1;56(23):5403-9.
6
Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.激素依赖性和非依赖性乳腺癌细胞系中pS2和组织蛋白酶D基因调控区域的染色质结构
Oncogene. 1999 Jan 14;18(2):533-41. doi: 10.1038/sj.onc.1202317.
7
Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.雌激素受体亲和力以及共有和不完全雌激素反应元件的位置影响简化启动子的转录激活。
Mol Endocrinol. 1996 Jun;10(6):694-704. doi: 10.1210/mend.10.6.8776729.
8
Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7.壬基酚对人乳腺癌细胞-MCF-7中pS2、雌激素受体和黏蛋白1基因表达的雌激素样作用。
Chem Biol Interact. 1997 Apr 18;104(1):55-64. doi: 10.1016/s0009-2797(97)03767-8.
9
Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.雌激素反应元件序列与配体之间的相互作用控制着雌激素受体在体内与调控基因的结合。
J Biol Chem. 2004 Feb 6;279(6):5025-34. doi: 10.1074/jbc.M307076200. Epub 2003 Nov 14.
10
A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer.第二种三叶因子蛋白,即ITF/hP1.B,在人类乳腺癌中被转录。
Breast Cancer Res Treat. 1996;38(2):145-51. doi: 10.1007/BF01806668.

引用本文的文献

1
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.PKMYT1 是 ER+ 乳腺癌对 CDK4/6 抑制剂耐药的治疗反应标志物和治疗靶点。
Mol Cancer Ther. 2024 Oct 1;23(10):1494-1510. doi: 10.1158/1535-7163.MCT-23-0564.
2
The effect of hesperetin on estrogen receptor gene expression and its relationship with the downstream pathways of estrogen receptor alpha.橙皮素对雌激素受体基因表达的影响及其与雌激素受体α下游途径的关系。
Mol Biol Rep. 2023 Sep;50(9):7225-7236. doi: 10.1007/s11033-023-08616-w. Epub 2023 Jul 7.
3
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
用于药物发现和精准肿瘤学的人乳腺癌衍生异种移植和类器官平台。
Nat Cancer. 2022 Feb;3(2):232-250. doi: 10.1038/s43018-022-00337-6. Epub 2022 Feb 24.
4
PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PBX1 的基因组先驱功能驱动 ERα 信号转导,从而导致乳腺癌的进展。
PLoS Genet. 2011 Nov;7(11):e1002368. doi: 10.1371/journal.pgen.1002368. Epub 2011 Nov 17.
5
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.激酶组筛选鉴定雌激素受体调节剂,发现 LMTK3 是乳腺癌的一个新的治疗靶点。
Nat Med. 2011 Jun;17(6):715-9. doi: 10.1038/nm.2351. Epub 2011 May 22.
6
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.紫花前胡素和紫花前胡醇当归酸酯可抑制雌激素刺激的以及雌激素非依赖性的乳腺癌细胞生长和存活。
Breast Cancer Res. 2007;9(6):R77. doi: 10.1186/bcr1790.
7
27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.27-羟基胆固醇是一种内源性选择性雌激素受体调节剂。
Mol Endocrinol. 2008 Jan;22(1):65-77. doi: 10.1210/me.2007-0383. Epub 2007 Sep 13.
8
Whole-genome cartography of estrogen receptor alpha binding sites.雌激素受体α结合位点的全基因组图谱
PLoS Genet. 2007 Jun;3(6):e87. doi: 10.1371/journal.pgen.0030087. Epub 2007 Apr 17.
9
pS2 is an independent factor of good prognosis in primary breast cancer.pS2是原发性乳腺癌预后良好的独立因素。
Br J Cancer. 1993 Jul;68(1):93-6. doi: 10.1038/bjc.1993.292.
10
Expression of pS2 protein in breast cancer.
Arch Gynecol Obstet. 1993;253(4):183-92. doi: 10.1007/BF02766644.